Insider · CIK 0001662521

Connaughton Bernadette

Reports to the SEC for 3 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001662521

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-10	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director	SSale	−1,626 sh	$102.80	−$167K	40,418
2026-07-01	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director	SSale	−1,000 sh	$76.39	−$76.4K	42,669
2026-07-01	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director	SSale	−625 sh	$77.21	−$48.3K	42,044
2026-06-17	EDITEditas Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+51.7K sh	—	—	51,700
2026-06-01	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director	SSale	−1,625 sh	$66.21	−$108K	43,669
2026-05-05	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+6,796 sh	—	—	45,294
2026-05-05	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	Director	AAward	+6,040 sh	—	—	6,040
2026-05-05	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+3,796 sh	—	—	42,294
2026-05-01	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director	SSale	−1,625 sh	$63.48	−$103K	38,498
2026-01-05	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director	SSale	−2,000 sh	$70.25	−$141K	40,123
2025-12-01	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director	SSale	−829 sh	$71.60	−$59.4K	42,123
2025-11-10	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director	SSale	−2,000 sh	$68.48	−$137K	42,952
2025-10-01	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director	SSale	−1,500 sh	$75.09	−$113K	45,452
2025-10-01	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director	SSale	−500 sh	$75.70	−$37.9K	44,952
2025-09-02	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director	SSale	−100 sh	$71.71	−$7,171	50,852
2025-09-02	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director	SSale	−2,977 sh	$73.62	−$219K	47,875
2025-09-02	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director	SSale	−923 sh	$74.11	−$68.4K	46,952
2025-06-06	EDITEditas Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+37.5K sh	—	—	37,500
2025-05-01	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+4,165 sh	—	—	50,952
2025-05-01	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	Director	AAward	+5,750 sh	—	—	5,750
2024-05-30	EDITEditas Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2024-04-25	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+6,501 sh	—	—	46,787
2024-04-25	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	Director	AAward	+8,804 sh	—	—	8,804
2023-09-28	Syneos Health, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−9,915 sh	$43.00	−$426K	4,863
2023-09-28	Syneos Health, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−4,863 sh	—	—	0
2023-06-01	EDITEditas Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-05-25	Syneos Health, Inc.A Award	Director	AAward	+4,863 sh	—	—	14,778
2023-05-05	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+8,065 sh	—	—	40,286
2023-05-05	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	Director	AAward	+11.4K sh	—	—	11,371
2022-11-16	HALOHALOZYME THERAPEUTICS, INC.G Gift	Director	GGift	−5,998 sh	—	—	32,221
2022-06-09	EDITEditas Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-05-25	Syneos Health, Inc.A Award	Director	AAward	+2,839 sh	—	—	9,915
2022-05-05	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+6,206 sh	—	—	38,219
2021-10-26	EDITEditas Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+24.7K sh	—	—	24,732
2021-05-12	Syneos Health, Inc.A Award	Director	AAward	+2,364 sh	—	—	7,076
2021-05-05	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+5,230 sh	—	—	32,013
2020-05-27	Syneos Health, Inc.A Award	Director	AAward	+2,803 sh	$62.43	+$175K	4,712
2020-04-30	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+8,829 sh	—	—	26,783
2019-11-12	Syneos Health, Inc.A Award	Director	AAward	+1,909 sh	$49.48	+$94.5K	1,909
2019-05-02	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+12.2K sh	—	—	17,954
2018-09-07	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+5,781 sh	—	—	5,781

Recent filings

Accepted (ET)
Oct 84/A
Connaughton Bernadette0001159036-26-000139
SEC(opens sec.gov)
Aug 114
Connaughton Bernadette0001662521-26-000002
SEC(opens sec.gov)
Jul 24
Connaughton Bernadette0001159036-26-000094
SEC(opens sec.gov)
Jun 224
Connaughton Bernadette0001650664-26-000072
SEC(opens sec.gov)
Jun 24
Connaughton Bernadette0001159036-26-000072
SEC(opens sec.gov)
May 74
Connaughton Bernadette0001159036-26-000059
SEC(opens sec.gov)
May 54
Connaughton Bernadette0001159036-26-000055
SEC(opens sec.gov)
Jan 64
Connaughton Bernadette0001159036-26-000006
SEC(opens sec.gov)
Dec 14
Connaughton Bernadette0001159036-25-000065
SEC(opens sec.gov)
Nov 124
Connaughton Bernadette0001159036-25-000052
SEC(opens sec.gov)
Oct 14
Connaughton Bernadette0001662521-25-000005
SEC(opens sec.gov)
Sep 24
Connaughton Bernadette0001415889-25-023470
SEC(opens sec.gov)
Jun 104
Connaughton Bernadette0001650664-25-000100
SEC(opens sec.gov)
May 24
Connaughton Bernadette0001415889-25-011767
SEC(opens sec.gov)

Companies

Address

C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL

SAN DIEGO, CA, 92130